Nerve conduction and its correlations with duration of diabetes mellitus and glycosylated haemoglobin in type 2 diabetes mellitus (T2DM)

References

• Zaccardi F, Webb DR, Yates T, et al. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–9.
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546.
   PubMedGoogle Scholar
• Bhutani J, Bhutani S. Worldwide burden of diabetes. Indian J Endocrinol Metab. 2014;18(6):868.
   PubMedGoogle Scholar
• Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health. 2013;13(1):387.
   PubMedGoogle Scholar
• Awadalla H, Noor SK, Elmadhoun WM, et al. Diabetes complications in Sudanese individuals with type 2 diabetes: overlooked problems in sub-Saharan Africa? Diab Metab Syndr Clin Res Rev. 2017;11:S1047–51.
   PubMed Web of Science ®Google Scholar
• Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41.
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54.
   PubMed Web of Science ®Google Scholar
• Picon AP, Ortega NR, Watari R, et al. Classification of the severity of diabetic neuropathy: a new approach taking uncertainties into account using fuzzy logic. Clinics. 2012;67(2):151–6.
   PubMed Web of Science ®Google Scholar
• Valls-Canals J, Povedano M, Montero J, et al. Diabetic polyneuropathy. axonal or demyelinating? Electromyogr Clin Neurophysiol. 2002;42(1):3–6.
   PubMedGoogle Scholar
• Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–62.
   PubMed Web of Science ®Google Scholar
• Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Res. 2016;5:738.
   Google Scholar
• Qureshi MS, Iqbal M, Zahoor S, et al. Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings. J Endocrinol Invest. 2017;40(4):425–30.
   PubMed Web of Science ®Google Scholar
• Garoushi S, Johnson MI, Tashani OA. Point prevalence of painful diabetic neuropathy in the Middle East and North Africa region: a systematic review with meta-analysis. Libyan J Med Sci. 2018 Jul 1;2(3):85.
   Google Scholar
• Masood A, Rizvi SA, Siddiqi SS, et al. A study on effects of HbA1c levels on nerve conduction velocity in type 2 diabetes mellitus patients. Int J Cur Res Rev. 2019;11(03):6–8.
   Google Scholar
• Themistocleous AC, Ramirez JD, Shillo PR, et al. The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain. 2016;157(5):1132–45.
   PubMed Web of Science ®Google Scholar
• Su JB, Zhao LH, Zhang XL, et al. Hba1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):47.
   PubMedGoogle Scholar
• Sunandini R, Somani SG. Median nerve conduction velocity as a tool to detect subclinical neuropathy in type II diabetes mellitus. Int J Physiol. 2016;4(1):103–9.
   Google Scholar
• Stevens MJ, Dananberg J, Feldman EL, et al. The linked roles of nitric oxide, aldose reductase and, (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 1994;94(2):853–9.
   PubMed Web of Science ®Google Scholar
• Greene DA, Arezzo JC, Brown MB, Zenarestat Study Group. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology. 1999;53(3):580.
   PubMed Web of Science ®Google Scholar
• Peterson M, Pingel R, Lagali N, et al. Association between HbA1c and peripheral neuropathy in a 10-year follow-up study of people with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes. Diabetic Med. 2017;34(12):1756–64.
   PubMed Web of Science ®Google Scholar
• Lai YR, Chiu WC, Huang CC, et al. Hba1c variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes. Front Neurosci. 2019;13:90.
   PubMed Web of Science ®Google Scholar
• Shah A, Shah D. To study clinical profile of peripheral neuropathy in type 2 diabetes mellitus using nerve conduction velocity. J Integr Health Sci. 2017;5(2):69.
   Google Scholar
• Chethan K, Sowjanya T. A study on the effect of duration of type 2 diabetes mellitus on nerve conduction velocity. Natl J Physiol Pharm Pharmacol. 2018;8(12):1622–4.
   Google Scholar
• de Souza RJ, de Souza A, Nagvekar MD. Nerve conduction studies in diabetics presymptomatic and symptomatic for diabetic polyneuropathy. Journal of Diabetes and its Complications. 2015 Aug 1;29(6):811–7.
   PubMed Web of Science ®Google Scholar
• Kim SE, Park KM, Park J, et al. Vascular factors and neuropathy in lower limb of diabetic patients. J Clin Neurosci. 2019;59:130–5.
   PubMed Web of Science ®Google Scholar